The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Akers Biosciences gets boost from new French regulation

Tue, 19th Feb 2013 11:27

Akers Biosciences was rewarded with a 11.3 per cent jump in its share price as the company announced a new product launch into the French market. The launch of disposable breath alcohol analysis tools is timely, as it coincides with a new French law coming into effect as of July 2012 citing that every driver of a motorised vehicle must carry at least one unused disposable breathalyser kit.The device from Akers, a provider of rapid diagnostic screening and testing products, has been approved by the French national reference laboratory, and further approval is expected this week from NF Mark. This will enable the product to be marketed and sold to consumers in and around France, as drivers must now comply with the new regulations. Prior to Aker's certification, there were only three disposable breathalyser brands that carried the all-important NF Mark.Akers has secured an exclusive, multi-year breathalyser distribution and supply agreement with Chubeworkx, which includes a $1.0m licensing fee. 3.5m breath alcohol detectors have already been ordered, to the value $1.05m, and further orders are expected as product demand is generated.Akers warned, on January 6th, that full-year revenues would be "significantly below expectations" due to delays to a large order to supply breath tubes to a US-based healthcare group. Chief executive officer Thomas Nicolette said he is hopeful the revenues from the French launch will support further growth for the company: "Having streamlined our manufacturing processes in 2012, the company is ready to deliver product to Chubeworkx on a schedule that will help meet French and EU market demand."JF 
More News
12 May 2016 08:18

Akers Biosciences Confident Of "Materially" Outperforming 2015

Read more
25 Apr 2016 14:07

Dr Akers steps down as Akers Bioscience chairman

(ShareCast News) - Rapid health information technology developer Akers Biosciences saw its founder and namesake Dr Raymond Akers step down as executive chairman on Monday, instead focusing on the firm's products and research. The AIM-traded company's current non-executive co-chairman, Thomas Knox, w

Read more
25 Apr 2016 11:09

Akers Biosciences Shuffles Board With Thomas Knox As Sole Chairman

Read more
30 Mar 2016 11:05

Akers Biosciences Loss Widens As Revenue Falls In 2015

Read more
23 Mar 2016 16:06

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Mar 2016 10:24

Akers Biosciences Secures US Patent For Heparin Assay Tests

Read more
2 Mar 2016 13:57

Akers Bioscience wins first China order for heparin test

(ShareCast News) - Akers Biosciences has won its first order from Chinese distributor NovoTek Therapeutics, worth $2.5m. The order is for Akers' handheld PIFA heparin allergy tests, which in November gained approval from the China Food and Drug Administration and will be exclusively sold and markete

Read more
2 Mar 2016 09:23

Akers Biosciences Wins USD2.5 Million Assay Tests Order For China

Read more
6 Jan 2016 10:01

DIRECTOR DEALINGS: Wife Of Akers Biosciences Chairman Buys Shares

Read more
1 Dec 2015 08:44

Akers Biosciences Says China Venture Production Facility Operational

Read more
23 Nov 2015 08:55

Akers Biosciences Appoints John Gormally As Chief Executive Officer

Read more
13 Nov 2015 10:30

WINNERS & LOSERS SUMMARY: Miners Recover, Rolls-Royce And IMI Down

Read more
13 Nov 2015 07:52

Akers Biosciences Outlook Dependent On Orders, Loss To Widen For 2015

Read more
11 Nov 2015 16:30

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Nov 2015 10:45

Akers Bioscience Gets Approval For Herapin Reaction Tests In China

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.